Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Molecular Biology and Phase II Study of Imetelstat (GRN163L) in Children With Recurrent High-Grade Glioma, Ependymoma and Diffuse Intrinsic Pontine Glioma

NCT01836549 is registered in ClinicalTrials.gov with Pediatric Brain Tumor Consortium as lead sponsor.

NCT NCT01836549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01836549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Molecular Biology and Phase II Study of Imetelstat (GRN163L) in Children With Recurrent High-Grade Glioma, Ependymoma and Diffuse Intrinsic Pontine Glioma
Lead sponsor
Pediatric Brain Tumor Consortium
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2013
Completion date
April 30, 2016
Enrollment
43 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic ependymoma, astrocytoma, grade ii, brainstem tumors, ependymoma, giant cell glioblastoma, glioblastoma, gliosarcoma, oligodendroglioma